EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-3.10 Cr | ₹-2.64 Cr | ₹2.07 Cr | ₹-2.05 Cr | ₹-3.36 Cr |
What is the latest Cash Flow from Financing Activities ratio of EVEREST ORGANICS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-3.10 Cr |
Mar2023 | ₹-2.64 Cr |
Mar2022 | ₹2.07 Cr |
Mar2021 | ₹-2.05 Cr |
Mar2020 | ₹-3.36 Cr |
How is Cash Flow from Financing Activities of EVEREST ORGANICS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-3.10 Cr | Negative | |
Mar2023 | ₹-2.64 Cr | Negative | |
Mar2022 | ₹2.07 Cr | Positive | |
Mar2021 | ₹-2.05 Cr | Negative | |
Mar2020 | ₹-3.36 Cr | - |
Compare Cash Flow from Financing Activities of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹382.8 Cr | -4.3% | 18.1% | 193.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | -4.3% |
18.1% |
193.2% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses